Roche?s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
[caption id="attachment_9277" align="aligncenter" width="747"] Press Release[/caption]
- First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs
- Testing on widely available, high-volume cobas 6800/8800 will significantly increase available testing capacity
- Roche expedites test development to support urgent need for patient testing during pandemic outbreak to avoid a further spread of the virus at an early stage of infection